Trinutra Ltd

Israël

Commandez votre montre hebdomadaire Trinutra Ltd
Quantité totale PI 19
Rang # Quantité totale PI 79 925
Note d'activité PI 1,8/5.0    9
Rang # Activité PI 101 934
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

5 6
1 1
5 0
1
 
Dernier brevet 2024 - Method for the treatment of micr...
Premier brevet 2017 - Compositions comprising melatonin
Dernière marque 2021 - B'UTYQUIN
Première marque 2017 - COGNIBEN

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Method for the treatment of microbial overgrowth, imbalance and infections. The present inventio...
2022 Invention Compositions comprising thymoquinone and omega-3 fatty acids. The present invention provides a c...
Invention Method for the treatment of microbial overgrowth, imbalance and infections. The present invention...
2021 P/S Nigella sativa cold pressed oil with high levels of thymoquinone for use as a raw ingredient in t...
2020 P/S Nutritional supplements containing omega 3 fatty acids and Nigella sativa oil
2019 P/S Black seed oil dietary supplements as raw material for use in the preparation of capsules, creams...
P/S Dietary supplements as raw material for the preparation of capsules, creams and liquid formulations.
P/S Black seed oil sold as a component of dietary supplements in capsule, cream, and liquid formulations
P/S Nutritional supplements containing astaxanthin and Nigella sativa oil
2018 Invention Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine. Ginkgo biloba, and...
Invention Compositions comprising thymoquinone and omega-3 fatty acids. The present invention provides a co...
2017 Invention Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine. ginkgo biloba, and...
Invention Synergistic combinations of caffeine, ginkgo biloba and β--phenylethylamine. The present inventio...
P/S Food supplements; oral compositions containing food supplements, namely, soft gel capsules, hard ...
P/S Dietary supplements in tablet form comprised of gingko biloba as a primary ingredient
Invention Anxiolytic compositions. The present invention is primarily directed to a therapeutic composition...
Invention Compositions comprising melatonin. The present invention provides a composition comprising a syne...